Evidence map›Paper›PMID 39401196›Full record

ArticlePLOS global public health2024

New admissions and asymptomatic TB cases seem to fuel TB epidemic in prisons, a cross sectional survey in Tanzania.

Chacha David Mangu, Petra Clowes, Jan van den Hombergh, Clement Mwakabenga, Simeon Mwanyonga, Jane Ambindwile, Faith Kayombo, Monica Minja, Samuel Kalluvya, Lisa Gerwing-Adima and 12 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Chacha David ManguNational Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania.ORCID https://orcid.org/0009-0006-7631-6812
Petra ClowesNational Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania.
Jan van den HomberghPharmAccess International, Dar es Salaam, Tanzania.
Clement MwakabengaNational Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania.
Simeon MwanyongaNational Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania.
Jane AmbindwileNational Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania.
Faith KayomboNational Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania.
Monica MinjaNational Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania.ORCID https://orcid.org/0009-0008-3572-2579
Samuel KalluvyaBugando Medical Centre, Mwanza, Tanzania.
Lisa Gerwing-AdimaBugando Medical Centre, Mwanza, Tanzania.
Christa KasangMedical Mission Institute, Wuerzburg, Germany.
Andreas MuellerMedical Mission Institute, Wuerzburg, Germany.
Edward ChiloloPharmAccess International, Dar es Salaam, Tanzania.
Juma AngolwisyeMinistry of Home Affairs, Prison Authority, Dodoma, Tanzania.
Dickson NsajigwaMinistry of Home Affairs, Prison Authority, Dodoma, Tanzania.
Adili KachimaMinistry of Home Affairs, Prison Authority, Dodoma, Tanzania.
Deus KamalaNational TB and Leprosy Program, Dodoma, Tanzania.
Beatrice MutayobyaNational TB and Leprosy Program, Dodoma, Tanzania.
Nyanda Elias NtinginyaNational Institute for Medical Research, Mbeya Medical Research Center, Mbeya, Tanzania.
Michael HoelscherDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Elmar SaathoffDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
Andrea RachowDivision of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is an increased risk for tuberculosis (TB) infection and disease progression in prison settings. TB prevalence in prisons in low- and middle-income countries have been measured to be up to 50 -times higher than in the general population. The aim of the study was to perform active TB screening and estimate the burden of TB in central prisons in Tanzania mainland. We performed TB active case finding in five central prisons, Keko, Segerea, Ukonga, Butimba and Ruanda prison in Tanzania, using the Xpert on early morning or spot sputum sample from inmates and new entries between April 2014 and July 2015. A questionnaire that asked about the symptoms and risk factors for TB was administered before a sputum sample was collected. Out of 13,868 incarcerated individuals tested, 13,763 had valid results. TB prevalence among tested was 1550 per 100,000 population (214/13,763); new admissions contributed to the majority (61.68%) of TB cases, but prevalence was higher among inmates (1.75%) compared to new admissions (1.45%). Ukonga, an urban prison which incarcerates long-term convicted inmates had the highest prevalence of 4.02%. Male gender (OR = 2.51, p<0.001), repeated incarcerations (OR = 2.85, p<0.001), history of TB treatment (OR = 1.78, p = 0.002), TB symptoms (OR = 2.78, p = 0.006) and HIV infection (OR = 2.86, p = 0.002) were associated with positive TB results. New admissions could be the driving force of the TB epidemic in the penitentiary system. However, prison environments remain a major risk factor for developing active TB disease.

Identifiers

PMID39401196
PMCPMC11472922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.